AAPL 186.44 -5.87 (-3.05%)MSFT 105.18 -1.86 (-1.74%)FB 142.18 -0.73 (-0.51%)ZNGA 3.54 -0.02 (-0.70%)NVDA 199.38 -1.21 (-0.60%)WBA 81.94 +0.17 (+0.21%)GOOG 1036.61 -5.93 (-0.57%)PIH 5.6 +0.15 (+2.75%)
AAPL 186.44 -5.87 (-3.05%)MSFT 105.18 -1.86 (-1.74%)FB 142.18 -0.73 (-0.51%)ZNGA 3.54 -0.02 (-0.70%)NVDA 199.38 -1.21 (-0.60%)WBA 81.94 +0.17 (+0.21%)GOOG 1036.61 -5.93 (-0.57%)PIH 5.6 +0.15 (+2.75%)

Financial Summary ELGX Quote Endologix I

Endologix Inc. Quote

Endologix Inc. (ELGX)

1.01 -0.02 Healthcare
Stock Performance rating :
Recommendation :
Strong Sell
Score :
C+
Symbol ELGX
Price 1.01
Beta 0.32
Vol Avg 726.65 K
Mkt cap 339.92 M
Shares 83
Last Div Not Available
Div Yield 0.00%
DCF Unlevered -82.06 Strong Sell
DCF Levered -66.06 Strong Sell
ROE -66.33% Strong Sell
ROA -21.53% Sell
Operating Margin -23.20% Sell
Debt/Equity 386.67% Strong Buy
P/E -1.27 Sell
P/B 1.12 Strong Buy
Company Profile

CEO

John McDermott

Sector

Healthcare

Industry

Medical Instruments & Equipment

Exchange

Nasdaq Global Select

Description

Endologix Inc develops, manufactures, markets and sells medical devices for the treatment of aortic disorders. Its products are intended for the treatment of abdominal aortic aneurysms.